Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma
Piotr Damiański, Anna Kumor-Kisielewska, Adam J Białas, Piotr Kuna, Maciej Kupczyk · 2026
Read Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma by Piotr Damiański, Anna Kumor-Kisielewska, Adam J Białas, Piotr Kuna, Maciej Kupczyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479083.txt.
Description
PurposeTo assess the effects of IL-5 pathway inhibition with mepolizumab or benralizumab on circulating eosinophil-related and selected remodeling-associated biomarkers in severe eosinophilic asthma (SEA), and to determine whether these profiles differ according to four-component study-defined early clinical remission (ECR) status.Patients and MethodsThis prospective, observational, single-center cohort study included 30 adults with SEA treated with mepolizumab or benralizumab.
Catalog record
| CREATOR | Piotr Damiański, Anna Kumor-Kisielewska, Adam J Białas, Piotr Kuna, Maciej Kupczyk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |